UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 443

Sortiert nach

Implementing a Death with Dignity Program at a Comprehensive Cancer Center

The New England journal of medicine, 2013-04, Vol.368 (15), p.1417-1424

2013

Link zum Volltext

Verfügbarkeit prüfen

Human Herpesvirus 6B and Lower Respiratory Tract Disease After Hematopoietic Cell Transplantation

Journal of clinical oncology, 2019-10, Vol.37 (29), p.2670-2681

2019

Link zum Volltext

Verfügbarkeit prüfen

Mitigation strategies for anti‐D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN® centres

Vox sanguinis, 2020-05, Vol.115 (4), p.334-338

2020

Link zum Volltext

Verfügbarkeit prüfen

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach

Bone marrow transplantation (Basingstoke), 2021-02, Vol.56 (2), p.305-313

2021

Link zum Volltext

Verfügbarkeit prüfen

Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report

Journal for immunotherapy of cancer, 2018-08, Vol.6 (1), p.82-9, Article 82

2018

Link zum Volltext

Verfügbarkeit prüfen

NCCN Roundtable: What Are the Characteristics of an Optimal Clinical Practice Guideline?

Journal of the National Comprehensive Cancer Network, 2015-05, Vol.13 (5 Suppl), p.640

2015

Link zum Volltext

Verfügbarkeit prüfen

Addressing Drug Resistance in Cancer: A Team Medicine Approach

Journal of clinical medicine, 2022-09, Vol.11 (19), p.5701

2022

Link zum Volltext

Verfügbarkeit prüfen

NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders

Journal of the National Comprehensive Cancer Network, 2010-09, Vol.8 Suppl 7, p.S7

2010

Link zum Volltext

Verfügbarkeit prüfen

High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study

The Lancet (British edition), 2000-03, Vol.355 (9208), p.999-1003

2000

Link zum Volltext

Verfügbarkeit prüfen

Responsibility for costs associated with clinical trials

Journal of clinical oncology, 2014-10, Vol.32 (30), p.3357-3359

2014

Link zum Volltext

Verfügbarkeit prüfen

Appreciating the role of advanced practice providers in oncology

Journal of the National Comprehensive Cancer Network, 2013-05, Vol.11 (5), p.508

2013

Link zum Volltext

Verfügbarkeit prüfen

Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer

JAMA network open, 2021-07, Vol.4 (7), p.e2118508-e2118508

2021

Link zum Volltext

Verfügbarkeit prüfen

Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms

Transplantation and cellular therapy, 2024-07, Vol.30 (7), p.727.e1-727.e8

2024

Link zum Volltext

Verfügbarkeit prüfen

Ensuring Patient Safety and Access in Cancer Care

Journal of the National Comprehensive Cancer Network, 2017-12, Vol.15 (12), p.1460

2017

Link zum Volltext

Verfügbarkeit prüfen

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys

Journal of the National Comprehensive Cancer Network, 2015-11, Vol.13 (11), p.1337

2015

Link zum Volltext

Verfügbarkeit prüfen

Development of a hematology/oncology ICD-10 documentation job aid

Journal of the National Comprehensive Cancer Network, 2015-04, Vol.13 (4), p.435

2015

Link zum Volltext

Verfügbarkeit prüfen

National Comprehensive Cancer Network Infusion Efficiency Workgroup Study: Optimizing Patient Flow in Infusion Centers

Journal of oncology practice, 2019-05, Vol.15 (5), p.e458

2019

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential Thrombocythemia

Biology of blood and marrow transplantation, 2007-03, Vol.13 (3), p.355-365

2007

Link zum Volltext

Verfügbarkeit prüfen

Influential factors for post-fellowship career decision-making: an NCCN survey

Journal of the National Comprehensive Cancer Network, 2012-08, Vol.10 (8), p.969

2012

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic Cell Transplantation after Solid Organ Transplantation

Biology of blood and marrow transplantation, 2015-12, Vol.21 (12), p.2123-2128

2015

Link zum Volltext

Verfügbarkeit prüfen

Revisiting the role of dose intensity in hematological malignancies

Experimental hematology, 2006-07, Vol.34 (7), p.811-825

2006

Link zum Volltext

Verfügbarkeit prüfen

Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy

Blood, 2002-07, Vol.100 (2), p.442-450

2002

Link zum Volltext

Verfügbarkeit prüfen

Esthesioneuroblastoma. Long term outcome and patterns of failure—the University of Virginia experience

Cancer, 1994-05, Vol.73 (10), p.2556-2562

1994

Link zum Volltext

Verfügbarkeit prüfen

Current practice for screening and management of financial distress at NCCN member institutions

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.11615-11615

2019

Link zum Volltext

Verfügbarkeit prüfen

Host marrow stem cell potential and engraftability at varying times after low-dose whole-body irradiation

Blood, 2001-08, Vol.98 (4), p.1246-1251

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 443

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(394)
Mit Volltextzugriff
(401)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Implementing a Death with Dignity Program at a Comprehensive Cancer Center

Human Herpesvirus 6B and Lower Respiratory Tract Disease After Hematopoietic Cell Transplantation

Mitigation strategies for anti‐D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN® centres

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach

Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report

NCCN Roundtable: What Are the Characteristics of an Optimal Clinical Practice Guideline?

Addressing Drug Resistance in Cancer: A Team Medicine Approach

NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders

High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study

Responsibility for costs associated with clinical trials

Appreciating the role of advanced practice providers in oncology

Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer

Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms

Ensuring Patient Safety and Access in Cancer Care

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys

Development of a hematology/oncology ICD-10 documentation job aid

National Comprehensive Cancer Network Infusion Efficiency Workgroup Study: Optimizing Patient Flow in Infusion Centers

Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential Thrombocythemia

Influential factors for post-fellowship career decision-making: an NCCN survey

Hematopoietic Cell Transplantation after Solid Organ Transplantation

Revisiting the role of dose intensity in hematological malignancies

Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy

Esthesioneuroblastoma. Long term outcome and patterns of failure—the University of Virginia experience

Current practice for screening and management of financial distress at NCCN member institutions

Host marrow stem cell potential and engraftability at varying times after low-dose whole-body irradiation

Suchergebnisse filtern